Tackling Lymphoma: Recent Advances in Immunotherapy

Laurie Sehn, MD, MPH

Join us as we report on the latest developments in immunotherapy from the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition that was hosted virtually December 5-8, 2020. In this episode, we will be speaking to Dr. Laurie Sehn, a Clinical Professor and Researcher with the British Columbia Cancer Centre for Lymphoid Cancer and The University of British Columbia. Immunotherapy was a primary topic at this year’s ASH meeting. Dr. Sehn shares exciting news about the advancements in immunotherapy for Non-Hodgkin Lymphoma. Hear why lymphoma is a great candidate for immunotherapy, how it works, and how a collaboration of researchers from around the world is accelerating the number of new and effective treatments available for lymphoma patients.

Support for this episode provided by Genentech and Pharmacyclics.

This podcast episode is NOT an official program of the ASH annual meeting.

CLICK HERE to participate in our episode survey.

Mentioned on this episode:

Additional LLS Support Resources:

2 Comments

  1. The information presented gave a broad picture of how CAR-T cells operate and how they are manipulated to help people like me. It was nice to have some of the gaps in what I already knew filled in and explained.
    I have received the latest CART-T cell therapy and it helped me greatly.

Leave a Comment

Your email address will not be published. Required fields are marked *